Literature DB >> 2016477

Gene transfer into vascular cells.

E G Nabel1, G Plautz, G J Nabel.   

Abstract

The goal of gene therapy is to introduce foreign deoxyribonucleic acid (DNA) into somatic cells to correct or prevent disorders caused by the malfunction of genes within a diseased individual. Overexpression of recombinant genes at specific sites within the vasculature can provide insights into vascular biology and potential treatments for various cardiovascular disorders such as restenosis. Methods for the introduction of foreign DNA into endothelial and vascular smooth muscle cells have been developed recently. These include the genetic modification of endothelium in vitro and implantation in vivo on arterial segments, direct infection of the arterial wall in vivo with a replication-defective retroviral vector expressing a recombinant gene and direct transfer of genes into vascular cells in vivo with use of liposomes. Although still in its formative stages, gene transfer into the vasculature holds promise as a potential treatment for vascular diseases, including atherosclerosis and restenosis. This approach may also provide insight into the role of specific gene products in the development of pathologic lesions.

Entities:  

Mesh:

Year:  1991        PMID: 2016477     DOI: 10.1016/0735-1097(91)90957-b

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

Review 1.  Cell physiology as a variable in gene transfer to endothelium.

Authors:  Philip L Leopold
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

Review 2.  A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine.

Authors:  Anna J Studwell; Darrell N Kotton
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

Review 3.  Recent advances in cardiology.

Authors:  C F Shakespeare; D J Coltart
Journal:  Postgrad Med J       Date:  1992-05       Impact factor: 2.401

Review 4.  Anti-tumor gene therapy.

Authors:  C Cirielli; M C Capogrossi; A Passaniti
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

5.  Vascular Applications of Human Gene Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

6.  Electroporation markedly improves Sleeping Beauty transposon-induced tumorigenesis in mice.

Authors:  S Jung; H-J Choi; H-K Park; W Jo; S Jang; J-E Ryu; W-J Kim; E-S Yu; W-C Son
Journal:  Cancer Gene Ther       Date:  2014-07-04       Impact factor: 5.987

Review 7.  Genetic approaches for changing the heart and dissecting complex syndromes.

Authors:  Michael-Alice Moga; Tomoki Nakamura; Jeffrey Robbins
Journal:  J Mol Cell Cardiol       Date:  2008-06-14       Impact factor: 5.000

8.  Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.

Authors:  R Schirmbeck; W Böhm; K Ando; F V Chisari; J Reimann
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Transfection efficiency and cytotoxicity of nonviral gene transfer reagents in human smooth muscle and endothelial cells.

Authors:  Karin Kiefer; Jule Clement; Patrick Garidel; Regine Peschka-Süss
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.